Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

EASTWEST MEDICO APS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   12.9% 8.5% 4.4% 8.7% 1.8% 1.6% 9.1% 8.9%   Credit score (0-100)   19 30 47 27 71 72 27 28   Credit rating   BB BB BBB BB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 8.4 13.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 10,525 37,589 0 0 0 0 0   Gross profit   536 500 3,430 2,178 9,988 7,189 0.0 0.0   EBITDA   536 493 1,911 -34.6 6,518 3,522 0.0 0.0   EBIT   535 476 1,892 -52.9 6,493 3,485 0.0 0.0   Pre-tax profit (PTP)   626.2 501.6 561.6 307.3 5,627.0 2,586.5 0.0 0.0   Net earnings   523.2 430.3 433.4 238.9 4,386.5 2,160.8 0.0 0.0   Pre-tax profit without non-rec. items   626 502 562 307 5,627 2,586 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   30.0 73.4 55.0 36.7 60.8 62.0 0.0 0.0   Shareholders equity total   468 699 1,132 1,371 5,758 3,628 3,508 3,508   Interest-bearing liabilities   45.9 218 320 114 206 144 0.0 0.0   Balance sheet total (assets)   5,798 1,170 7,798 32,181 13,154 7,322 3,508 3,508   Net Debt   -826 117 -4,270 -3,017 -7,295 -5,123 -3,508 -3,508     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 10,525 37,589 0 0 0 0 0   Net sales growth   0.0% 0.0% 257.1% -100.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   536 500 3,430 2,178 9,988 7,189 0.0 0.0   Gross profit growth   0.0% -6.7% 586.2% -36.5% 358.6% -28.0% -100.0% 0.0%   Employees   0 0 2 4 4 4 0 0   Employee growth %   0.0% 0.0% 0.0% 100.0% 0.0% 10.5% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,798 1,170 7,798 32,181 13,154 7,322 3,508 3,508   Balance sheet change%   1,882.2% -79.8% 566.6% 312.7% -59.1% -44.3% -52.1% 0.0%   Added value   535.6 493.4 1,910.6 -34.6 6,511.3 3,521.7 0.0 0.0   Added value %   0.0% 4.7% 5.1% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   29 26 -37 -37 -1 -35 -62 0   Net sales trend   0.0 0.0 1.0 -1.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 4.7% 5.1% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 4.5% 5.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   99.8% 95.2% 55.2% -2.4% 65.0% 48.5% 0.0% 0.0%   Net Earnings %   0.0% 4.1% 1.2% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 4.3% 1.2% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 4.8% 1.5% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.5% 18.7% 43.3% 3.4% 35.1% 36.4% 0.0% 0.0%   ROI %   228.7% 90.8% 163.6% 46.1% 212.0% 75.7% 0.0% 0.0%   ROE %   137.5% 73.7% 47.3% 19.1% 123.1% 46.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   8.1% 59.7% 14.5% 4.3% 43.8% 49.6% 100.0% 100.0%   Relative indebtedness %   0.0% 4.5% 17.7% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 3.5% 5.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -154.2% 23.6% -223.5% 8,720.4% -111.9% -145.5% 0.0% 0.0%   Gearing %   9.8% 31.1% 28.3% 8.3% 3.6% 4.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   145.9% 113.4% 513.2% 170.6% 1,448.1% 649.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.1 0.4 1.2 1.0 1.5 1.9 0.0 0.0   Current Ratio   1.1 2.3 1.2 1.0 1.8 2.0 0.0 0.0   Cash and cash equivalent   871.9 101.0 4,590.4 3,131.7 7,501.4 5,267.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 30.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 1.9 26.8 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 10.1% 20.5% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   410.0 597.7 1,048.9 1,304.7 5,715.6 3,613.9 0.0 0.0   Net working capital %   0.0% 5.7% 2.8% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 18,794 0 0 0 0 0   Added value / employee   0 0 955 -9 1,628 797 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 955 -9 1,629 797 0 0   EBIT / employee   0 0 946 -13 1,623 788 0 0   Net earnings / employee   0 0 217 60 1,097 489 0 0